Table 4 Results of cost-effectiveness analysis when only direct health care costs were considered in the analysis
Direct comparison | Total cost | Incremental cost | ICER |
|---|---|---|---|
| Â | Â | Agomelatine vs. comparator | Â |
Agomelatine | €1,970 | - | - |
Venlafaxine | €1,620 | €350 | €13,682/QALY |
Sertraline | €1,701 | €269 | €7,959/QALY |
Escitalopram | €1,816 | €154 | €10,591/QALY |
Fluoxetine | €1,697 | €273 | €9,183/QALY |
Generic Venlafaxine | €1,597 | €373 | €14,581/QALY |
Generic Sertraline | €1,651 | €319 | €9,434/QALY |
Generic Escitalopram | €1,740 | €230 | €15,799/QALY |
Generic Fluoxetine | €1,642 | €328 | €11,027/QALY |